97 related articles for article (PubMed ID: 2299969)
21. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
22. Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets.
Golden A; Brugge JS
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):901-5. PubMed ID: 2464830
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase C-dependent and Ca2+-dependent mechanisms of secretion from streptolysin O-permeabilized platelets: effects of leakage of cytosolic proteins.
Sloan DC; Haslam RJ
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):13-21. PubMed ID: 9359828
[TBL] [Abstract][Full Text] [Related]
24. [Effect of phorbol ester on protein kinase C and tyrosine protein kinase in human hepatocarcinoma cell line].
Chai XY
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):182-4. PubMed ID: 7903236
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of phorbol 12-myristate 13-acetate and prostaglandin E1 on calcium regulation in human platelets.
Yoshida K; Stark F; Nachmias VT
Biochem J; 1988 Jan; 249(2):487-93. PubMed ID: 2829859
[TBL] [Abstract][Full Text] [Related]
26. Translocation, activation and association of protein-tyrosine kinase (p72syk) with phosphatidylinositol 3-kinase are early events during platelet activation.
Yanagi S; Sada K; Tohyama Y; Tsubokawa M; Nagai K; Yonezawa K; Yamamura H
Eur J Biochem; 1994 Sep; 224(2):329-33. PubMed ID: 7925345
[TBL] [Abstract][Full Text] [Related]
27. Phorbol myristate acetate inhibits thrombin-stimulated Ca2+ mobilization and phosphatidylinositol 4,5-bisphosphate hydrolysis in human platelets.
Zavoico GB; Halenda SP; Sha'afi RI; Feinstein MB
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3859-62. PubMed ID: 2987951
[TBL] [Abstract][Full Text] [Related]
28. 1,2-Dioctanoylglycerol but not 1-oleoyl-2-acetylglycerol inhibits agonist-induced platelet responses. Dependence of effects on extent of 45-kDa protein phosphorylation and agonist type.
Krishnamurthi S; Joseph S; Kakkar VV
Eur J Biochem; 1987 Sep; 167(3):585-93. PubMed ID: 3653105
[TBL] [Abstract][Full Text] [Related]
29. Effect of propranolol on platelet signal transduction.
Dash D; Rao K
Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):99-104. PubMed ID: 7619088
[TBL] [Abstract][Full Text] [Related]
30. Response of aequorin-loaded platelets to activators of protein kinase C.
Ware JA; Saitoh M; Smith M; Johnson PC; Salzman EW
Am J Physiol; 1989 Jan; 256(1 Pt 1):C35-43. PubMed ID: 2912135
[TBL] [Abstract][Full Text] [Related]
31. Staurosporine potentiates platelet activating factor stimulated phospholipase C activity in rabbit platelets but does not block desensitization by platelet activating factor.
Morrison WJ; Dhar A; Shukla SD
Life Sci; 1989; 45(4):333-9. PubMed ID: 2761347
[TBL] [Abstract][Full Text] [Related]
32. Tumour-promoting phorbol esters inhibit agonist-induced phosphatidate formation and Ca2+ flux in human platelets.
MacIntyre DE; McNicol A; Drummond AH
FEBS Lett; 1985 Jan; 180(2):160-4. PubMed ID: 2981715
[TBL] [Abstract][Full Text] [Related]
33. Regulation of sn-1,2-diacylglycerol second-messenger formation in thrombin-stimulated human platelets. Potentiation by protein kinase C inhibitors.
Bishop WR; August J; Petrin JM; Pai JK
Biochem J; 1990 Jul; 269(2):465-73. PubMed ID: 2386487
[TBL] [Abstract][Full Text] [Related]
34. Phorbol myristate acetate enhances adenylate cyclase activity in human polymorphonuclear leukocytes.
Rebut-Bonneton C; Demignon J; Sourbier P
Horm Metab Res; 1990 Mar; 22(3):175-8. PubMed ID: 2160909
[TBL] [Abstract][Full Text] [Related]
35. Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells.
Kobayashi Y; Bridle KR; Ramm GA; O'neill R; Britton RS; Bacon BR
Liver Int; 2007 Oct; 27(8):1066-75. PubMed ID: 17845534
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of phorbol ester-induced protein kinase activity in human neutrophils by platelet-activating factor.
Gay JC; Stitt ES
J Cell Physiol; 1988 Dec; 137(3):439-47. PubMed ID: 3192624
[TBL] [Abstract][Full Text] [Related]
37. The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen.
Hargreaves PG; Licking EF; Sargeant P; Sage SO; Barnes MJ; Farndale RW
Thromb Haemost; 1994 Oct; 72(4):634-42. PubMed ID: 7878644
[TBL] [Abstract][Full Text] [Related]
38. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets.
Lipfert L; Haimovich B; Schaller MD; Cobb BS; Parsons JT; Brugge JS
J Cell Biol; 1992 Nov; 119(4):905-12. PubMed ID: 1385445
[TBL] [Abstract][Full Text] [Related]
39. Thrombin and activators of protein kinase C modulate secretory responses of permeabilised human platelets induced by Ca2+.
Knight DE; Niggli V; Scrutton MC
Eur J Biochem; 1984 Sep; 143(2):437-46. PubMed ID: 6236084
[TBL] [Abstract][Full Text] [Related]
40. Receptor-mediated regulation of leukotriene C4 synthase activity in human platelets.
Tornhamre S; Edenius C; Lindgren JA
Eur J Biochem; 1995 Dec; 234(2):513-20. PubMed ID: 8536697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
